Search results
Results From The WOW.Com Content Network
The fifth version in 1957 saw its name change to The British National Formulary. [ 4 ] [ 5 ] A new-look version, under the auspices of Owen Wade , was released in 1981. [ 2 ] [ 6 ] A study in Northern Ireland, looking at prescribing in 1965, reported that the BNF was likely able to serve the requirements of prescribers in general practice ...
The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child. The guidance was provided by pharmacists and doctors whose expertise was in the care of adults.
The British Pharmacopoeia is an important statutory component in the control of medicines, which complements and assists the licensing and inspection processes of the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Together with the British National Formulary (BNF), the British Pharmacopoeia defines the UK's pharmaceutical ...
A national formulary contains a list of medicines that are approved for prescription throughout the country, indicating which products are interchangeable. It includes key information on the composition, description, selection, prescribing, dispensing and administration of medicines.
Monographs summarize the nomenclature, properties, actions, and uses of each substance. A chapter on supplementary drugs and other substances covers monographs on new drugs, those not easily classified, herbals, and drugs no longer clinically used but still of interest. Monographs of some toxic substances are also included.
The 1934 edition was described by the British Medical Journal as "one of the most useful reference books available to the medical profession". [ 1 ] In 1963 Edward G Feldmann, director of revision for the US National Formulary, described it as "a compilation of highly authoritative and useful therapeutic (actions and doses) information as well ...
Pharmaceutical Press is the publishing arm of the Royal Pharmaceutical Society (formerly the Royal Pharmaceutical Society of Great Britain).It is a provider of independent pharmaceutical information.
Manage the Clinical Practice Research Datalink and the British Pharmacopoeia. The MHRA hosts and supports a number of expert advisory bodies, including the British Pharmacopoeia Commission, and the Commission on Human Medicine which replaced the Committee on the Safety of Medicines in 2005. [citation needed]